These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7632202)

  • 21. Chronic fatigue: risk factors for symptom persistence in a 2 1/2-year follow-up study.
    Clark MR; Katon W; Russo J; Kith P; Sintay M; Buchwald D
    Am J Med; 1995 Feb; 98(2):187-95. PubMed ID: 7847436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
    Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
    Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The specificity of the CDC-1994 criteria for chronic fatigue syndrome: comparison of health status in three groups of patients who fulfill the criteria.
    Kennedy G; Abbot NC; Spence V; Underwood C; Belch JJ
    Ann Epidemiol; 2004 Feb; 14(2):95-100. PubMed ID: 15018881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population.
    Solomon L; Nisenbaum R; Reyes M; Papanicolaou DA; Reeves WC
    Health Qual Life Outcomes; 2003 Oct; 1():48. PubMed ID: 14577835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic function and serum erythropoietin levels in chronic fatigue syndrome.
    Winkler AS; Blair D; Marsden JT; Peters TJ; Wessely S; Cleare AJ
    J Psychosom Res; 2004 Feb; 56(2):179-83. PubMed ID: 15016575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide concentrations are normal and unrelated to activity level in chronic fatigue syndrome: a case-control study.
    Meeus M; VAN Eupen I; Hondequin J; DE Hauwere L; Kos D; Nijs J
    In Vivo; 2010; 24(6):865-9. PubMed ID: 21164046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity.
    Reuter SE; Evans AM
    J Intern Med; 2011 Jul; 270(1):76-84. PubMed ID: 21205027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unexplained fever and chronic fatigue: abnormal circadian temperature pattern.
    Camus F; Henzel D; Janowski M; Raguin G; Leport C; Vildé JL
    Eur J Med; 1992 Apr; 1(1):30-6. PubMed ID: 1341974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection.
    Gow JW; Simpson K; Behan PO; Chaudhuri A; McKay IC; Behan WM
    Clin Infect Dis; 2001 Dec; 33(12):2080-1. PubMed ID: 11698994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of case definitions of chronic fatigue syndrome.
    Bates DW; Buchwald D; Lee J; Kith P; Doolittle TH; Umali P; Komaroff AL
    Clin Infect Dis; 1994 Jan; 18 Suppl 1():S11-5. PubMed ID: 8148436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of chronic fatigue syndrome who showed a beneficial effect by intravenous administration of magnesium sulphate].
    Takahashi H; Imai K; Katanuma A; Sugaya T; Hisano K; Motoya S; Aoki S; Sugiyama T; Yachi A
    Arerugi; 1992 Nov; 41(11):1605-10. PubMed ID: 1492795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review of laboratory findings for patients with chronic fatigue syndrome.
    Buchwald D; Komaroff AL
    Rev Infect Dis; 1991; 13 Suppl 1():S12-8. PubMed ID: 1902321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic fatigue: myth or reality?].
    Comtois R
    Union Med Can; 1991; 120(1):10-6. PubMed ID: 2021024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin subclass levels in chronic fatigue syndrome.
    Bennett AL; Fagioli LR; Schur PH; Schacterle RS; Komaroff AL
    J Clin Immunol; 1996 Nov; 16(6):315-20. PubMed ID: 8946275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome.
    De Meirleir K; Bisbal C; Campine I; De Becker P; Salehzada T; Demettre E; Lebleu B
    Am J Med; 2000 Feb; 108(2):99-105. PubMed ID: 11126321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability of the RNase L isoform ratio (37 kiloDaltons/83 kiloDaltons) in diagnosis of chronic fatigue syndrome.
    Tiev KP; Briant M; Ziani M; Cabane J; Demettre E; Lebleu B
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):366. PubMed ID: 15699437
    [No Abstract]   [Full Text] [Related]  

  • 37. Fatigue, brain, behavior, and immunity: summary of the 2012 Named Series on fatigue.
    Bower JE
    Brain Behav Immun; 2012 Nov; 26(8):1220-3. PubMed ID: 22964543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clues to chronic fatigue syndrome.
    Komaroff AL
    Health News; 2000 Apr; 6(4):3. PubMed ID: 15356884
    [No Abstract]   [Full Text] [Related]  

  • 39. C-Reactive Protein Response in Patients With Post-Treatment Lyme Disease Symptoms Versus Those With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Uhde M; Indart A; Fallon BA; Wormser GP; Marques AR; Vernon SD; Alaedini A
    Clin Infect Dis; 2018 Sep; 67(8):1309-1310. PubMed ID: 29741589
    [No Abstract]   [Full Text] [Related]  

  • 40. Canada bans blood donations from people with history of chronic fatigue syndrome.
    Kermode-Scott B
    BMJ; 2010 Apr; 340():c1974. PubMed ID: 20382678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.